Clinical Trial of Mitoxantrone HCL Liposome Injection in Patients With Relapsed DLBCL and PT/NKCLs

CMOP±R in the Treatment of Untreated Non-Hodgkin's Lymphoma

NCT06486337 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Liposomal Mitoxantrone Hydrochloride Injection,Cyclophosphamide, Vincristine and Prednisone in the Treatment of PTCL

NCT04548700 ·Status: TERMINATED ·Phase: PHASE1

R-MINE+X in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

NCT05784987 ·Status: UNKNOWN ·Phase: NA

A Study of Rocbrutinib in Participants With Relapse or Refractory Mantle Cell Lymphoma

NCT05716087 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)

NCT06106841 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS

NCT03573310 ·Status: COMPLETED ·Phase: PHASE1

Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)

NCT03213678 ·Status: COMPLETED ·Phase: PHASE2

SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma.

NCT05293912 ·Status: TERMINATED ·Phase: PHASE1

Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects

NCT06074107 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

An Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Combination With Tiragolumab With or Without Atezolizumab in Participants With B-Cell Non-Hodgkin Lymphoma

NCT05315713 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

F01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma

NCT06206902 ·Status: RECRUITING ·Phase: PHASE1

Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma

NCT00742027 ·Status: COMPLETED ·Phase: PHASE2

An Open, Multicenter Phase II Study to Evaluate the Safety and Efficacy of KL-A167 Injection in Relapsed or Refractory Classical Hodgkin's Lymphoma

NCT03580564 ·Status: COMPLETED ·Phase: PHASE2

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

NCT01638533 ·Status: COMPLETED ·Phase: PHASE1

Phase I/II Study of Linperlisib Plus Chidamide for R/R Peripheral T-cell Lymphoma: a Prospective, Multi-center Study

NCT06083701 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma

NCT00901147 ·Status: COMPLETED ·Phase: PHASE2

Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F)

NCT05490771 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of TQ-B3101 in Subjects With Relapsed or Refractory Anaplastic Large Cell Lymphoma (ALCL)

NCT04306887 ·Status: UNKNOWN ·Phase: PHASE2

HMPL-760 in Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

NCT05190068 ·Status: COMPLETED ·Phase: PHASE1

GVM±R in Patients With Relapsed or Refractory Aggressive NHL

NCT05299164 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Phase 2 Study of SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

NCT02653976 ·Status: COMPLETED ·Phase: PHASE2

Phase II of High-dose Therapy in Elderly Patients With Relapsed Aggressive NHL or Resistant to First Line Therapy

NCT02371161 ·Status: UNKNOWN ·Phase: PHASE2

A Study of GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL

NCT05627856 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)

NCT05784441 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL)

NCT01090973 ·Status: TERMINATED ·Phase: PHASE2